Patents by Inventor Howard M. Goodman

Howard M. Goodman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5145777
    Abstract: A plant cell which is resistant to a herbicidal glutamine synthetase inhibitor, wherein the resistance is caused by levels of GS activity which, when present in an otherwise herbicidal GS inhibitor sensitive plant cell, render the cell substantially resistant to the herbicidal GS-inhibitor.
    Type: Grant
    Filed: May 9, 1991
    Date of Patent: September 8, 1992
    Assignee: The General Hospital Corporation
    Inventors: Howard M. Goodman, Gunter Donn
  • Patent number: 4935235
    Abstract: What is disclosed is a protein immunoreactive with antibodies raised against HBsAg, which protein has the formula: X-S-Y, S represents a peptide residue of the hepatitis B virus S-protein, Y is OH or NH.sub.2 and X is selected from the pre-S1/pre-S2 peptide residue, the pre S2 peptide residue and a fragment of the pre-S1/pre-S2 peptide residue containing at least a 9 amino acid portion of the C-terminal sequence of pre-S2.
    Type: Grant
    Filed: December 1, 1987
    Date of Patent: June 19, 1990
    Assignee: The Regents of the University of California
    Inventors: William J. Rutter, Howard M. Goodman
  • Patent number: 4820642
    Abstract: A DNA expression vector which contains the trp promotor is described. The expression vector provides for the overproduction of .beta.-lactamase. Insertion of a gene or cDNA into the .beta.-lactamase gene of the expression vector results in the over-production of a fusion protein comprising a part of the .beta.-lactamase as the N-terminal end and the protein coded for by the inserted DNA as the C-terminal end. Using the expression vector described herein, it is possible to obtain large amounts of the fusion protein. A fusion protein containing the surface antigen of Hepatitis B virus and a vaccine containing this fusion protein are also described.
    Type: Grant
    Filed: April 4, 1983
    Date of Patent: April 11, 1989
    Assignee: The Regents of the University of California
    Inventors: Jeffrey C. Edman, William J. Rutter, Robert A. Hallewell, Pablo D. T. Valenzuela, Howard M. Goodman
  • Patent number: 4652525
    Abstract: A recombinant procaryotic microorganism containing the gene coding for insulin.
    Type: Grant
    Filed: June 28, 1983
    Date of Patent: March 24, 1987
    Assignee: The Regents of the University of California
    Inventors: William J. Rutter, Raymond Pictet, John Chirgwin, Howard M. Goodman, Axel Ullrich, John Shine
  • Patent number: 4447538
    Abstract: A microorganism containing a recombinant DNA transfer vector having the coding sequences for human chorionic somatomammotropin.
    Type: Grant
    Filed: February 5, 1982
    Date of Patent: May 8, 1984
    Assignee: Regents of the University of California
    Inventors: Howard M. Goodman, John Shine, Peter H. Seeburg
  • Patent number: 4440859
    Abstract: Microorganism having a gene derived from a higher organism is produced by isolating cells from a higher organism containing messenger RNA, extracting the messenger RNA, synthesizing a double stranded cDNA using the messenger RNA as a template, inserting the cDNA into a plasmid and transforming a microorganism with the resultant recombinant plasmid.
    Type: Grant
    Filed: September 11, 1981
    Date of Patent: April 3, 1984
    Assignee: The Regents of the University of California
    Inventors: William J. Rutter, Howard M. Goodman, Axel Ullrich, John Shine, John Chirgwin, Raymond Pictet
  • Patent number: 4431740
    Abstract: A DNA having a base sequence coding for human proinsulin and a DNA having a base sequence coding for human pre-proinsulin have been cloned, and novel recombinant DNA transfer vectors containing said cloned DNAs have been constructed. Novel microorganisms transformed by said recombinant transfer vectors have been obtained. Certain of said transformed microorganisms have demonstrated capability to express the cloned DNA's, synthesizing a protein comprising human proinsulin and a protein-comprising human pre-proinsulin.
    Type: Grant
    Filed: June 8, 1982
    Date of Patent: February 14, 1984
    Assignee: The Regents of the University of California
    Inventors: Graeme Bell, Raymond Pictet, Howard M. Goodman, William J. Rutter
  • Patent number: 4407948
    Abstract: A method for purifying a DNA fragment of specific desired nucleotide sequence containing a restriction site, from a population of DNA molecules homogeneous in length by endonuclease cleavage and fractionation.
    Type: Grant
    Filed: February 5, 1982
    Date of Patent: October 4, 1983
    Assignee: The Regents of the University of California
    Inventors: Howard M. Goodman, John Shine, Peter H. Seeburg
  • Patent number: 4363877
    Abstract: Recombinant DNA transfer vectors containing codons for human somatomammotropin and for human growth hormone.
    Type: Grant
    Filed: April 19, 1978
    Date of Patent: December 14, 1982
    Assignee: The Regents of the University of California
    Inventors: Howard M. Goodman, John Shine, Peter H. Seeburg
  • Patent number: 4322499
    Abstract: A technique suitable for cloning a cDNA having a base sequence coding for the ACTH/LPH precursor is disclosed. The invention is exemplified by the cloning of a cDNA fragment comprising a base sequence coding for the endorphin region. The fragment, hereinafter termed the endorphin gene cDNA sequence, was obtained from cultured mouse pituitary tumor cells known to produce the ACTH/LPH precursor protein.
    Type: Grant
    Filed: December 22, 1978
    Date of Patent: March 30, 1982
    Assignee: The Regents of the University of California
    Inventors: John D. Baxter, James L. Roberts, Peter H. Seeburg, Howard M. Goodman, John Shine
  • Patent number: 4283489
    Abstract: A method has been discovered for purifying a specific desired DNA sequence, starting from RNA heterogeneous in length and sequence. The steps of the method include making complementary DNA transcripts of the RNA by means of an enzyme such as reverse transcriptase, subjecting the DNA transcripts to the action of one or more selected restriction endonuclease enzymes, and fractionating the fragments produced by endonuclease action according to their length. By this method it is possible to isolate homogeneous length DNA fragments complementary to RNA sequences present in the original preparation in as low a frequency as two percent. A method is also disclosed for further purifying the homogeneous length fragments and for determining their final purity. Using the disclosed methods, a DNA fragment approximately 550 nucleotides in length coding for a portion of the peptide hormone, human chorionic somatomammotropin, has been purified to greater than 99% purity.
    Type: Grant
    Filed: November 23, 1979
    Date of Patent: August 11, 1981
    Assignee: The Regents of the University of California
    Inventors: Howard M. Goodman, John Shine, Peter Horst